Cipla — 360° view

Cipla, a company in the Pharmaceuticals industry, reported revenue of ₹7,404 crore and net profit of ₹852 crore for the September 2026 quarter.

Cipla (NSE: CIPLA) closed at ₹1,415.00 on 20 Nov 2026, down 7.5% over the past year. Its market capitalisation is ₹1,14,316 crore and it trades at 36.8 times earnings.

Share price
₹1,415.00 (20 Nov 2026)
Market cap
₹1,14,316 Cr (20 Nov 2026)
P/E
36.81 (20 Nov 2026)
Revenue
₹7,404 Cr (September 2026 quarter)
Net profit
₹852 Cr (September 2026 quarter)
ROCE
15.5% (FY26)
ROE
11.6% (FY26)
Book value
₹438 (FY26)
Dividend yield
0.92% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,539.70 / ₹1,165.70 (20 Nov 2026)
1-year return
-7.5% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: CIPLA

Incorporated in 1935, Cipla Ltd is in the business of manufacturing, developing, and marketing a wide range of branded and generic formulations and APIs

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.